IP Verse

Use Of Biomarkers In The Assessment Of The Early Transition From Arterial Hypertension To Heart Failure

Patent No. EP2609427 (titled "Use Of Biomarkers In The Assessment Of The Early Transition From Arterial Hypertension To Heart Failure") was filed by F Hoffmann LA Roche on Aug 3, 2011. The application was issued on Jan 21, 2015.

Patent Summary

Patent Family

Patent family tree
Statuses, jurisdictions and citation links are shared on request.

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
ADAMSOct 21, 2015MATHYS & SQUIRE

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

EP2609427

F HOFFMANN LA ROCHE
Application Number
EP11743231A
Filing Date
Aug 3, 2011
Status
Revoked
May 19, 2021
Publication Date
Jan 21, 2015
External Links
Slate, Register , Google Patents